AMPE Investors Have Opportunity to Lead Ampio Pharmaceuticals, Inc. Securities Fraud LawsuitPRNewsWire • 10/13/22
MONDAY DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 10/13/22
AMPE LAWSUIT ALERT: Levi & Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlinePRNewsWire • 10/13/22
Ampio Class Action: Levi & Korsinsky Reminds Ampio Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 17, 2022 - AMPENewsfile Corp • 10/13/22
ROSEN, Global Investor Counsel, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPENewsfile Corp • 10/10/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ampio Pharmaceuticals, Inc. - AMPENewsfile Corp • 10/08/22
ROSEN, LEADING INVESTOR COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPEPRNewsWire • 10/08/22
Ampio Pharmaceuticals Announces NYSE American Has Commenced Delisting ProceedingsPRNewsWire • 10/04/22
AMPE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 17, 2022 in the Class Action Filed on Behalf of Ampio Pharmaceuticals, Inc. ShareholdersPRNewsWire • 10/04/22
NYSE American to Suspend Trading Immediately in Ampio Pharmaceuticals, Inc. (AMPE) and Commence Delisting ProceedingsBusiness Wire • 10/03/22
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Ampio Investors of a Lead Plaintiff Deadline of October 17, 2022PRNewsWire • 10/03/22
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPENewsfile Corp • 10/01/22
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPEPRNewsWire • 09/28/22
TOP RANKED ROSEN LAW FIRM Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPENewsfile Corp • 09/19/22
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPENewsfile Corp • 09/16/22
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPEPRNewsWire • 09/15/22
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/15/22
ROSEN, A TOP RANKED FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - AMPENewsfile Corp • 09/14/22
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/13/22
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPENewsfile Corp • 09/11/22
AMPE LOSS ALERT: ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPEPRNewsWire • 09/09/22
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/08/22
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/06/22
ROSEN, A LEADING LAW FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPEPRNewsWire • 09/01/22
